TITLE

Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis

AUTHOR(S)
Allen, Upton D.; Navas, Lissette; King, Susan M.
PUB. DATE
December 1993
SOURCE
CMAJ: Canadian Medical Association Journal;12/1/1993, Vol. 149 Issue 11, p1659
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
35471097

 

Related Articles

  • POSTNATAL PENICILLIN PROPHYLAXIS OF EARLY-ONSET GROUP B STREPTOCOCCAL INFECTION IN TERM NEWBORNS: A PRELIMINARY STUDY. Stillova, Lucia; Strechova, Zuzana; Matasova, Katarina; Kolarovszka, Hana; Bodova, Kristina; Stilla, Juraj; Zibolen, Mirko // Biomedical Papers of the Medical Faculty of Palacky University i;2007, Vol. 151 Issue 1, p79 

    Background: Early-onset group B Streptococcal disease (EOGBSD) is a serious but preventable neonatal infection. Maternal intrapartum antibiotic prophylaxis (IAP) does not prevent all cases of the disease. Management of asymptomatic neonates of GBS colonized mothers is problematic. Aims: The...

  • Neonatal Early-onset Group B Streptococcal Disease in the Era of Intrapartum Chemoprophylaxis: Residual Problems. Pinto, Nelangi M; Soskolne, Errol I; Pearlman, Mark D; Faix, Roger G // Journal of Perinatology;Jun2003, Vol. 23 Issue 4, p265 

    OBJECTIVE: To identify limitations of current strategies for intrapartum prophylaxis of neonatal early-onset group B streptococcal infection. METHODS: Retrospective review of infants with culture-proven early-onset group B streptococcal infection admitted to two nurseries and their mothers from...

  • Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC, 2010.  // MMWR Recommendations & Reports;11/19/2010, Vol. 59 Issue RR-10, p1 

    Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the United States. In 1996, CDC, in collaboration with relevant professional societies, published guidelines for the...

  • Prevention of Perinatal Group B Streptococcal Disease. Verani, Jennifer R.; McGee, Lesley; Schrag, Stephanie J. // MMWR: Morbidity & Mortality Weekly Report;11/19/2010, Vol. 59 Issue 45, p1 

    Despite substantial progress in prevention of perinatal group B streptococcal (GBS) disease since the 1990s, GBS remains the leading cause of early-onset neonatal sepsis in the United States. In 1996, CDC, in collaboration with relevant professional societies, published guidelines for the...

  • A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates. Schrag, Stephanie J.; Zell, Elizabeth R.; Lynfield, Ruth; Roome, Aaron; Arnold, Kathryn E.; Craig, Allen S.; Harrison, Lee H.; Reingold, Arthur; Stefonek, Karen; Smith, Glenda; Gamble, Melanie; Schuchat, Anne // New England Journal of Medicine;7/25/2002, Vol. 347 Issue 4, p233 

    Background: Guidelines issued in 1996 in the United States recommend either screening of pregnant women for group B streptococcal colonization by means of cultures (screening approach) or assessing clinical risk factors (risk-based approach) to identify candidates for intrapartum antibiotic...

  • Preventing group B streptococcal disease: which strategy best?  // PharmacoEconomics & Outcomes News;8/13/2005, Issue 484, p8 

    Reports that a risk-based strategy for preventing early-onset group B streptococcal disease among neonates has a reasonable cost-effectiveness ratio, according to researchers from The Netherlands. Treatment strategies with intrapartum antibacterial prophylaxis to prevent group B streptococcal...

  • Early-Onset Neonatal Group B Streptococcal Sepsis: Intrapartum Antibiotic Prophylaxis in the Clinical Setting. Gervasio, Clarissa T; Mantaring, Blesile S; Alankar, Sudha; Shankaran, Seetha // Journal of Perinatology;Jan2001, Vol. 21 Issue 1, p9 

    OBJECTIVE: To evaluate how guidelines for the use of intrapartum antibiotics for the prevention of early-onset Group B streptococcal infection are utilized in a clinical setting. STUDY DESIGN: Review of maternal/infant records for the year 1993 in a perinatal center. RESULTS: Intrapartum...

  • Revised Guidelines for Perinatal Group B Streptococcal Disease. Jenson, Hal B. // Infectious Disease Alert;Jan2011, Vol. 30 Issue 4, p44 

    The 2002 guidelines for prevention of perinatal group B streptococcal disease have been updated with expanded recommendations on laboratory methods, revised algorithms for screening and intrapartum chemoprophylaxis, a change in the recommended dose of penicillin G, updated prophylaxis regimens...

  • Maternal screening to prevent neonatal Group B streptococcal disease.  // Journal of Medical Screening;Dec2002, Vol. 9 Issue 4, p191 

    Focuses on maternal screening to prevent neonatal Group B streptococcal disease. Prevalence and mortality; Screening tests; Intrapartum antibiotic prophylaxis; Efficacy; Assessment.

  • Screening for Group B Streptococcus: A Private Hospital's Experience. Faro, Sebastian; Brehm, Brenda; Smith, Frances; Mouzoon, Melanie; Greisinger, Anthony; Wehmanen, Oscar; Turrentine, Mark A. // Infectious Diseases in Obstetrics & Gynecology;2010, Vol. 2010, Special section p1 

    Objective. To assess the effect of universal screening and administration of intrapartum antibiotic prophylaxis to prevent earlyonset neonatal GBS sepsis at a private tertiary care hospital since issuance of the 2002 CDC guidelines for preventing perinatal GBS disease. Methods. Retrospective...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics